BX Swiss TOP 30 CHF
1.430,81
PKT
+5,28
PKT
+0,37
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.01.21 | Swiss Re Outperform | RBC Capital Markets | |
| 27.01.21 | UBS buy | Kepler Cheuvreux | |
| 27.01.21 | UBS buy | Goldman Sachs Group Inc. | |
| 27.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Novartis Neutral | Credit Suisse Group | |
| 27.01.21 | UBS Outperform | Credit Suisse Group | |
| 27.01.21 | UBS Underweight | Barclays Capital | |
| 26.01.21 | Roche buy | Goldman Sachs Group Inc. | |
| 26.01.21 | UBS Neutral | UBS AG | |
| 26.01.21 | Novartis buy | UBS AG | |
| 26.01.21 | Novartis overweight | Morgan Stanley | |
| 26.01.21 | UBS Equal-Weight | Morgan Stanley | |
| 26.01.21 | Novartis Hold | Kepler Cheuvreux | |
| 26.01.21 | UBS buy | Kepler Cheuvreux | |
| 26.01.21 | UBS Sector Perform | RBC Capital Markets | |
| 26.01.21 | UBS Neutral | Goldman Sachs Group Inc. | |
| 26.01.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 26.01.21 | Novartis buy | Jefferies & Company Inc. | |
| 25.01.21 | Roche Reduce | Oddo BHF | |
| 25.01.21 | Novartis Neutral | Oddo BHF | |
| 25.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.01.21 | Swiss Re Neutral | Credit Suisse Group | |
| 22.01.21 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.21 | Holcim overweight | Morgan Stanley | |
| 22.01.21 | Roche overweight | Barclays Capital | |
| 22.01.21 | Novartis Underweight | Barclays Capital | |
| 22.01.21 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 21.01.21 | Holcim overweight | JP Morgan Chase & Co. | |
| 21.01.21 | Swiss Re Halten | DZ BANK | |
| 21.01.21 | UBS Outperform | Credit Suisse Group | |
| 21.01.21 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 20.01.21 | Holcim overweight | Barclays Capital | |
| 20.01.21 | Holcim buy | UBS AG | |
| 20.01.21 | Holcim buy | UBS AG | |
| 20.01.21 | Novartis Neutral | Credit Suisse Group | |
| 20.01.21 | Roche Neutral | Credit Suisse Group | |
| 20.01.21 | Novartis buy | Jefferies & Company Inc. | |
| 20.01.21 | Roche buy | Jefferies & Company Inc. | |
| 19.01.21 | Novartis Underweight | JP Morgan Chase & Co. |